id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0597-0053,FDA,FDA-2011-D-0597,Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring,Other,Guidance,2013-08-07T04:00:00Z,2013,8,2013-08-07T04:00:00Z,,2024-11-07T22:58:12Z,,1,0,0900006481395793
FDA-2011-D-0597-0052,FDA,FDA-2011-D-0597,Guidance for Industry on Oversight of Clinical Investigations--A Risk-Based Approach to Monitoring; Availability,Notice,Notice of Availability,2013-08-07T04:00:00Z,2013,8,2013-08-07T04:00:00Z,,2015-07-07T16:52:03Z,2013-19004,0,0,0900006481394d5e